

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation (GO:0006956) | 9.19952627 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 7.70369443 |
| 3 | protein activation cascade (GO:0072376) | 6.82044208 |
| 4 | glomerular filtration (GO:0003094) | 6.48193808 |
| 5 | renal filtration (GO:0097205) | 5.89571043 |
| 6 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.50992319 |
| 7 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.50992319 |
| 8 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.50992319 |
| 9 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.48897734 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.28657040 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.20348317 |
| 12 | humoral immune response (GO:0006959) | 5.07295909 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.05605923 |
| 14 | regulation of respiratory burst (GO:0060263) | 5.04455564 |
| 15 | antimicrobial humoral response (GO:0019730) | 4.40532319 |
| 16 | antibacterial humoral response (GO:0019731) | 4.36628009 |
| 17 | daunorubicin metabolic process (GO:0044597) | 4.35017532 |
| 18 | polyketide metabolic process (GO:0030638) | 4.35017532 |
| 19 | doxorubicin metabolic process (GO:0044598) | 4.35017532 |
| 20 | retina homeostasis (GO:0001895) | 4.29423867 |
| 21 | regulation of cellular extravasation (GO:0002691) | 4.10325169 |
| 22 | progesterone metabolic process (GO:0042448) | 4.10324064 |
| 23 | detection of bacterium (GO:0016045) | 4.05580200 |
| 24 | detection of other organism (GO:0098543) | 4.03211052 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.91098030 |
| 26 | surfactant homeostasis (GO:0043129) | 3.85787978 |
| 27 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.84545708 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.74657944 |
| 29 | negative regulation of cell killing (GO:0031342) | 3.74657944 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.66305002 |
| 31 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.44935565 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43368042 |
| 33 | arginine catabolic process (GO:0006527) | 3.38192677 |
| 34 | negative regulation of complement activation (GO:0045916) | 3.35187811 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35141800 |
| 36 | germinal center formation (GO:0002467) | 3.31069037 |
| 37 | intestinal absorption (GO:0050892) | 3.26143351 |
| 38 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.20622969 |
| 39 | regulation of antigen processing and presentation (GO:0002577) | 3.18260314 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.13641470 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.13641470 |
| 42 | negative regulation of humoral immune response (GO:0002921) | 3.10543315 |
| 43 | response to type I interferon (GO:0034340) | 3.10046855 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.07246427 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06141458 |
| 46 | negative regulation of protein activation cascade (GO:2000258) | 3.00387737 |
| 47 | detection of external biotic stimulus (GO:0098581) | 2.99611023 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96389310 |
| 49 | respiratory burst (GO:0045730) | 2.95257537 |
| 50 | production of molecular mediator of immune response (GO:0002440) | 2.95126582 |
| 51 | negative regulation of myotube differentiation (GO:0010832) | 2.89073491 |
| 52 | protein-chromophore linkage (GO:0018298) | 2.88834194 |
| 53 | cellular response to interferon-gamma (GO:0071346) | 2.87240016 |
| 54 | chronic inflammatory response (GO:0002544) | 2.80439261 |
| 55 | C21-steroid hormone metabolic process (GO:0008207) | 2.75041956 |
| 56 | B cell mediated immunity (GO:0019724) | 2.72661507 |
| 57 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.71802131 |
| 58 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.71738153 |
| 59 | response to interferon-gamma (GO:0034341) | 2.71028595 |
| 60 | activation of immune response (GO:0002253) | 2.68188175 |
| 61 | interferon-gamma secretion (GO:0072643) | 2.68160347 |
| 62 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.67805669 |
| 63 | positive regulation of pseudopodium assembly (GO:0031274) | 2.67608495 |
| 64 | immune response-activating signal transduction (GO:0002757) | 2.67264399 |
| 65 | dendritic cell chemotaxis (GO:0002407) | 2.66695610 |
| 66 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.64349724 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 2.63612323 |
| 68 | oligosaccharide biosynthetic process (GO:0009312) | 2.60806189 |
| 69 | intestinal cholesterol absorption (GO:0030299) | 2.59529617 |
| 70 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.58511016 |
| 71 | chemical homeostasis within a tissue (GO:0048875) | 2.57608723 |
| 72 | defense response to Gram-negative bacterium (GO:0050829) | 2.53188684 |
| 73 | detection of biotic stimulus (GO:0009595) | 2.53090992 |
| 74 | regulation of chemokine secretion (GO:0090196) | 2.50726448 |
| 75 | glycoside metabolic process (GO:0016137) | 2.49480061 |
| 76 | arginine metabolic process (GO:0006525) | 2.48789305 |
| 77 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48534805 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 2.47764453 |
| 79 | regulation of regulatory T cell differentiation (GO:0045589) | 2.45629098 |
| 80 | dendritic cell migration (GO:0036336) | 2.43106100 |
| 81 | regulation of guanylate cyclase activity (GO:0031282) | 2.42621818 |
| 82 | regulation of monocyte chemotaxis (GO:0090025) | 2.42414176 |
| 83 | retinal metabolic process (GO:0042574) | 2.40415217 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.40213141 |
| 85 | T-helper 1 type immune response (GO:0042088) | 2.39958899 |
| 86 | peptide catabolic process (GO:0043171) | 2.38650014 |
| 87 | positive regulation of chemokine secretion (GO:0090197) | 2.38185543 |
| 88 | cellular extravasation (GO:0045123) | 2.37951722 |
| 89 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.37648237 |
| 90 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37575152 |
| 91 | regulation of pseudopodium assembly (GO:0031272) | 2.36415520 |
| 92 | leukocyte aggregation (GO:0070486) | 2.35819681 |
| 93 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.35733248 |
| 94 | regulation of macrophage chemotaxis (GO:0010758) | 2.35142067 |
| 95 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.34231022 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.31658277 |
| 97 | regulation of necrotic cell death (GO:0010939) | 2.29240527 |
| 98 | regulation of complement activation (GO:0030449) | 2.29092520 |
| 99 | wound healing, spreading of epidermal cells (GO:0035313) | 2.28858734 |
| 100 | complement activation, classical pathway (GO:0006958) | 11.5026996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.32529862 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.40986048 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.45583122 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.24681627 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.31405991 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.07508105 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.99211040 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.83854637 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44417272 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39341977 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31543783 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.20107279 |
| 13 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.11221921 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06230600 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.03421822 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96044849 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95501806 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.92035799 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89470279 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88360080 |
| 21 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.80465742 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78660584 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.78075582 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.67844113 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63555974 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63068742 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61003770 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60684089 |
| 29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.60208181 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.58820410 |
| 31 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.58746259 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54852661 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47898703 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.47028510 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44268360 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.44054860 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42902437 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.41084261 |
| 39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40031103 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38079423 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35758363 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32097551 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30745364 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29339569 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28831743 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26223542 |
| 47 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25620893 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24691986 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24646512 |
| 50 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24339009 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23652540 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23115976 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22613818 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22174897 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21773900 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21350408 |
| 57 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.20797835 |
| 58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20407215 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19809093 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17763375 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.16392984 |
| 62 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15607503 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15025664 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15003735 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13171560 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11996998 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10408462 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09797905 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.08848387 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06479539 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06153373 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04969256 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04067561 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01997074 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01529269 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00085718 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97751937 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96888565 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96778805 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96261149 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95728339 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95041395 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94908997 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94908997 |
| 85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94222423 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91972551 |
| 87 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89837547 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.89670870 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89230283 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88428768 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88134525 |
| 92 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.85981276 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85907244 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85640253 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84453028 |
| 96 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84105699 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83444007 |
| 98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83408957 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81828292 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81174174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.51154182 |
| 2 | MP0003303_peritoneal_inflammation | 3.39654110 |
| 3 | MP0004782_abnormal_surfactant_physiolog | 3.17202476 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.13702715 |
| 5 | MP0003436_decreased_susceptibility_to | 3.04802190 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.93555557 |
| 7 | MP0001790_abnormal_immune_system | 2.78186584 |
| 8 | MP0005387_immune_system_phenotype | 2.78186584 |
| 9 | MP0010155_abnormal_intestine_physiology | 2.76051998 |
| 10 | MP0009785_altered_susceptibility_to | 2.60394612 |
| 11 | MP0001800_abnormal_humoral_immune | 2.56529841 |
| 12 | MP0005025_abnormal_response_to | 2.48897309 |
| 13 | MP0005671_abnormal_response_to | 2.27805632 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.25520635 |
| 15 | MP0005166_decreased_susceptibility_to | 2.25172635 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.22084471 |
| 17 | MP0005275_abnormal_skin_tensile | 2.21491449 |
| 18 | MP0000685_abnormal_immune_system | 2.18997800 |
| 19 | MP0004858_abnormal_nervous_system | 2.17566889 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 2.12767255 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.08520080 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.06398466 |
| 23 | MP0004947_skin_inflammation | 2.06135680 |
| 24 | MP0002419_abnormal_innate_immunity | 2.03129738 |
| 25 | MP0008004_abnormal_stomach_pH | 1.94530757 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.93687869 |
| 27 | MP0002723_abnormal_immune_serum | 1.92885907 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.92346829 |
| 29 | MP0001819_abnormal_immune_cell | 1.79355208 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.77686420 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.77221032 |
| 32 | MP0003075_altered_response_to | 1.76391447 |
| 33 | MP0002796_impaired_skin_barrier | 1.75969776 |
| 34 | MP0006082_CNS_inflammation | 1.72063453 |
| 35 | MP0003866_abnormal_defecation | 1.71205920 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.65931811 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.59083458 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.57343024 |
| 39 | MP0001873_stomach_inflammation | 1.56002816 |
| 40 | MP0003448_altered_tumor_morphology | 1.55983596 |
| 41 | MP0000343_altered_response_to | 1.53368220 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.51098054 |
| 43 | MP0003329_amyloid_beta_deposits | 1.46322536 |
| 44 | MP0000604_amyloidosis | 1.42591425 |
| 45 | MP0005023_abnormal_wound_healing | 1.39506373 |
| 46 | MP0005164_abnormal_response_to | 1.38695731 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.38062282 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.35566212 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.35347770 |
| 50 | MP0001663_abnormal_digestive_system | 1.27283050 |
| 51 | MP0000858_altered_metastatic_potential | 1.27180319 |
| 52 | MP0000716_abnormal_immune_system | 1.25976263 |
| 53 | MP0002405_respiratory_system_inflammati | 1.23038688 |
| 54 | MP0008469_abnormal_protein_level | 1.19833576 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.18676672 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.18652158 |
| 57 | MP0002398_abnormal_bone_marrow | 1.17340209 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.08680872 |
| 59 | MP0009764_decreased_sensitivity_to | 1.08604432 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.05716731 |
| 61 | MP0003828_pulmonary_edema | 1.04636504 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.04324374 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.03345148 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.02323456 |
| 65 | MP0002006_tumorigenesis | 1.02108783 |
| 66 | MP0001664_abnormal_digestion | 1.01190689 |
| 67 | MP0003279_aneurysm | 1.00807658 |
| 68 | MP0005390_skeleton_phenotype | 0.99987826 |
| 69 | MP0000249_abnormal_blood_vessel | 0.99386735 |
| 70 | MP0001851_eye_inflammation | 0.99229156 |
| 71 | MP0005310_abnormal_salivary_gland | 0.98111671 |
| 72 | MP0000477_abnormal_intestine_morphology | 0.98033443 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.97592539 |
| 74 | MP0002429_abnormal_blood_cell | 0.97456274 |
| 75 | MP0005165_increased_susceptibility_to | 0.95094036 |
| 76 | MP0001216_abnormal_epidermal_layer | 0.95081564 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.94728611 |
| 78 | MP0002933_joint_inflammation | 0.93959873 |
| 79 | MP0010678_abnormal_skin_adnexa | 0.93853517 |
| 80 | MP0005503_abnormal_tendon_morphology | 0.93242543 |
| 81 | MP0003045_fibrosis | 0.91217905 |
| 82 | MP0002133_abnormal_respiratory_system | 0.90472976 |
| 83 | MP0005388_respiratory_system_phenotype | 0.90472976 |
| 84 | MP0005381_digestive/alimentary_phenotyp | 0.88694834 |
| 85 | MP0000490_abnormal_crypts_of | 0.87635947 |
| 86 | MP0009840_abnormal_foam_cell | 0.87016273 |
| 87 | MP0002722_abnormal_immune_system | 0.86789831 |
| 88 | MP0000689_abnormal_spleen_morphology | 0.83538524 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.82858596 |
| 90 | MP0001542_abnormal_bone_strength | 0.82848548 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.81028634 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.77984782 |
| 93 | MP0001958_emphysema | 0.77060076 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.77011568 |
| 95 | MP0003795_abnormal_bone_structure | 0.76384988 |
| 96 | MP0001666_abnormal_nutrient_absorption | 0.75141378 |
| 97 | MP0005365_abnormal_bile_salt | 0.74922785 |
| 98 | MP0002060_abnormal_skin_morphology | 0.74815057 |
| 99 | MP0004883_abnormal_blood_vessel | 0.74636987 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.74005770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.21859791 |
| 2 | Prostate neoplasm (HP:0100787) | 6.11718381 |
| 3 | Abnormality of macrophages (HP:0004311) | 5.29007909 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.53585448 |
| 5 | Abnormality of the prostate (HP:0008775) | 4.48406421 |
| 6 | Abnormality of complement system (HP:0005339) | 4.09854252 |
| 7 | Complement deficiency (HP:0004431) | 3.89259874 |
| 8 | Vasculitis (HP:0002633) | 3.86701517 |
| 9 | Glomerulonephritis (HP:0000099) | 3.82633831 |
| 10 | Increased IgE level (HP:0003212) | 3.66204854 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.43797980 |
| 12 | Malnutrition (HP:0004395) | 3.40345308 |
| 13 | Nephritis (HP:0000123) | 3.24367128 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.22781949 |
| 15 | Urticaria (HP:0001025) | 3.21566422 |
| 16 | Leukocytosis (HP:0001974) | 3.19820856 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.13349409 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.09201020 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.08086287 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.06754700 |
| 21 | Premature loss of primary teeth (HP:0006323) | 3.04359588 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.04348346 |
| 23 | Pustule (HP:0200039) | 3.02181547 |
| 24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.01848244 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99194050 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 2.97000358 |
| 27 | Agammaglobulinemia (HP:0004432) | 2.96601512 |
| 28 | Skin rash (HP:0000988) | 2.95926592 |
| 29 | Gastrointestinal stroma tumor (HP:0100723) | 2.93595983 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 2.93502064 |
| 31 | Myositis (HP:0100614) | 2.90129160 |
| 32 | Gingivitis (HP:0000230) | 2.84770012 |
| 33 | Meningitis (HP:0001287) | 2.80440255 |
| 34 | Alopecia of scalp (HP:0002293) | 2.73029470 |
| 35 | Orchitis (HP:0100796) | 2.72507843 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.71958509 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69812577 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.65006619 |
| 39 | Cellulitis (HP:0100658) | 2.62403469 |
| 40 | Abnormality of male internal genitalia (HP:0000022) | 2.58832285 |
| 41 | Osteomyelitis (HP:0002754) | 2.56139897 |
| 42 | Hypergammaglobulinemia (HP:0010702) | 2.54279103 |
| 43 | Colitis (HP:0002583) | 2.53495080 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.52381585 |
| 45 | Periodontitis (HP:0000704) | 2.45814389 |
| 46 | Hemoptysis (HP:0002105) | 2.44371574 |
| 47 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.40600788 |
| 48 | Villous atrophy (HP:0011473) | 2.40600788 |
| 49 | Chronic otitis media (HP:0000389) | 2.37748764 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.37166416 |
| 51 | Chronic diarrhea (HP:0002028) | 2.37080746 |
| 52 | Recurrent skin infections (HP:0001581) | 2.33811812 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33690571 |
| 54 | Obstructive lung disease (HP:0006536) | 2.33690571 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.31824906 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.27556405 |
| 57 | Thick nail (HP:0001805) | 2.25901039 |
| 58 | Palmoplantar hyperkeratosis (HP:0000972) | 2.25864684 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.24720413 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.24316281 |
| 61 | Xerostomia (HP:0000217) | 2.22281097 |
| 62 | Skin ulcer (HP:0200042) | 2.19440733 |
| 63 | Recurrent viral infections (HP:0004429) | 2.18392903 |
| 64 | Neoplasm of the lung (HP:0100526) | 2.17882815 |
| 65 | Optic neuritis (HP:0100653) | 2.17490385 |
| 66 | Retrobulbar optic neuritis (HP:0100654) | 2.17490385 |
| 67 | Purpura (HP:0000979) | 2.15560578 |
| 68 | Abnormality of nail color (HP:0100643) | 2.15280856 |
| 69 | Mediastinal lymphadenopathy (HP:0100721) | 2.12298001 |
| 70 | Hypermelanotic macule (HP:0001034) | 2.10773535 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.10528375 |
| 72 | Increased IgM level (HP:0003496) | 2.08868296 |
| 73 | Palmar hyperkeratosis (HP:0010765) | 2.07345452 |
| 74 | Gingival bleeding (HP:0000225) | 2.06992319 |
| 75 | Recurrent fungal infections (HP:0002841) | 2.06673738 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.06526796 |
| 77 | Emphysema (HP:0002097) | 2.06130004 |
| 78 | Plantar hyperkeratosis (HP:0007556) | 2.04943749 |
| 79 | Bronchitis (HP:0012387) | 2.01880568 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.01284034 |
| 81 | Decreased circulating renin level (HP:0003351) | 1.99741598 |
| 82 | Gangrene (HP:0100758) | 1.98527152 |
| 83 | Ankyloglossia (HP:0010296) | 1.96019708 |
| 84 | Chest pain (HP:0100749) | 1.95835122 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 1.92680838 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.90832543 |
| 87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.90832543 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 1.90832543 |
| 89 | Erythema (HP:0010783) | 1.90144763 |
| 90 | Peritonitis (HP:0002586) | 1.89426094 |
| 91 | Granulocytopenia (HP:0001913) | 1.89185875 |
| 92 | Keratoconjunctivitis (HP:0001096) | 1.88814370 |
| 93 | Fragile skin (HP:0001030) | 1.86103972 |
| 94 | Verrucae (HP:0200043) | 1.85826706 |
| 95 | Papilloma (HP:0012740) | 1.85826706 |
| 96 | Restrictive lung disease (HP:0002091) | 1.85745705 |
| 97 | Neoplasm of the respiratory system (HP:0100606) | 1.83365285 |
| 98 | Abnormal hair laboratory examination (HP:0003328) | 1.83150786 |
| 99 | Alkalosis (HP:0001948) | 1.83058344 |
| 100 | Polycythemia (HP:0001901) | 1.83021337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.14026951 |
| 2 | MST1R | 4.12670280 |
| 3 | TYK2 | 3.07719208 |
| 4 | MAP4K1 | 3.03139895 |
| 5 | BLK | 2.81423294 |
| 6 | PIK3CA | 2.77744926 |
| 7 | EPHA3 | 2.61186366 |
| 8 | RIPK4 | 2.51539854 |
| 9 | FGFR4 | 2.46483293 |
| 10 | EPHB1 | 2.37084076 |
| 11 | EPHA2 | 2.28865157 |
| 12 | PRPF4B | 2.10547331 |
| 13 | ZAP70 | 2.06162564 |
| 14 | RIPK1 | 2.03899857 |
| 15 | JAK1 | 1.87183345 |
| 16 | FES | 1.75100507 |
| 17 | JAK3 | 1.73157774 |
| 18 | GRK6 | 1.68748329 |
| 19 | CSK | 1.63345922 |
| 20 | MAP3K14 | 1.62148318 |
| 21 | TXK | 1.58389010 |
| 22 | KIT | 1.58091436 |
| 23 | FGFR3 | 1.55532058 |
| 24 | CDC42BPA | 1.53426129 |
| 25 | MET | 1.50432733 |
| 26 | IKBKE | 1.47635876 |
| 27 | IRAK4 | 1.43629003 |
| 28 | FER | 1.35470354 |
| 29 | MAP3K1 | 1.30692876 |
| 30 | TBK1 | 1.30023957 |
| 31 | LYN | 1.29199365 |
| 32 | JAK2 | 1.25810392 |
| 33 | ACVR1B | 1.22237338 |
| 34 | MAP3K3 | 1.21363084 |
| 35 | TAOK1 | 1.20371722 |
| 36 | IRAK1 | 1.17463529 |
| 37 | SYK | 1.11223899 |
| 38 | STK24 | 1.10687492 |
| 39 | SIK3 | 1.09642788 |
| 40 | MAP3K13 | 1.07092888 |
| 41 | MATK | 1.04225319 |
| 42 | MAP2K3 | 1.02122674 |
| 43 | CSF1R | 1.00187225 |
| 44 | NLK | 0.99939787 |
| 45 | BTK | 0.99375836 |
| 46 | TGFBR2 | 0.98531895 |
| 47 | BMPR2 | 0.98381510 |
| 48 | YES1 | 0.93988122 |
| 49 | EPHB2 | 0.90500536 |
| 50 | HCK | 0.90495439 |
| 51 | MAP3K6 | 0.86385564 |
| 52 | LRRK2 | 0.85169418 |
| 53 | MAP3K12 | 0.83773806 |
| 54 | FGR | 0.77259325 |
| 55 | PRKG2 | 0.76472163 |
| 56 | TGFBR1 | 0.71770119 |
| 57 | PTK6 | 0.70968957 |
| 58 | LCK | 0.70921363 |
| 59 | TAOK3 | 0.70058469 |
| 60 | PDGFRA | 0.69836811 |
| 61 | TESK1 | 0.67107784 |
| 62 | LMTK2 | 0.66558321 |
| 63 | RET | 0.64726004 |
| 64 | ITK | 0.64414044 |
| 65 | PAK4 | 0.63027526 |
| 66 | FYN | 0.62658306 |
| 67 | MAPK7 | 0.57915931 |
| 68 | PKN2 | 0.55895723 |
| 69 | MAP2K6 | 0.55375388 |
| 70 | HIPK2 | 0.54465836 |
| 71 | MYLK | 0.52546538 |
| 72 | IKBKB | 0.52513219 |
| 73 | CDK6 | 0.51807424 |
| 74 | KSR2 | 0.50209326 |
| 75 | TEC | 0.50073485 |
| 76 | PDGFRB | 0.48155540 |
| 77 | MAP3K10 | 0.47414525 |
| 78 | PDPK1 | 0.46073600 |
| 79 | BMX | 0.45259784 |
| 80 | MAPKAPK2 | 0.44922048 |
| 81 | MAP3K2 | 0.42367870 |
| 82 | IGF1R | 0.42110690 |
| 83 | GRK5 | 0.42035624 |
| 84 | TAOK2 | 0.41039649 |
| 85 | DDR2 | 0.40757056 |
| 86 | TRIB3 | 0.40375963 |
| 87 | DMPK | 0.39268028 |
| 88 | MAP3K11 | 0.38680776 |
| 89 | PDK1 | 0.37242618 |
| 90 | STK39 | 0.34839220 |
| 91 | TESK2 | 0.34813528 |
| 92 | TNK2 | 0.33872412 |
| 93 | SMG1 | 0.33035354 |
| 94 | PRKCD | 0.32868066 |
| 95 | IRAK3 | 0.32663321 |
| 96 | ABL1 | 0.32652842 |
| 97 | PRKCQ | 0.31667887 |
| 98 | SRC | 0.31086817 |
| 99 | MAP3K5 | 0.29292266 |
| 100 | MAP2K2 | 0.27039193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.97603341 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.22251120 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.00443187 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.91256065 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.83088952 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72395243 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.65339773 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.54389701 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.29429588 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20871335 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.17112011 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07534347 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.99501434 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.82899820 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.67060466 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64245601 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62874618 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62239273 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56493160 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.52444006 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.50348665 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.39524712 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35113557 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26224081 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.26035992 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.25190039 |
| 27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.24916255 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23344022 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21521922 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17361985 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09010162 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07644528 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06589148 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.06281014 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05620277 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03665744 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99895194 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97149058 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96133082 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94050140 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93414827 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92043794 |
| 43 | Measles_Homo sapiens_hsa05162 | 0.91694753 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91371558 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 0.89667737 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89358790 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88979421 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88035626 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.87915453 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86440100 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86129022 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85946508 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81345544 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80825262 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80689634 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.77038143 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76828381 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.75922599 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.74026562 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71116604 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70747609 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70057301 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66647853 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66645211 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66455354 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65116679 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.64633997 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64040070 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61945889 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61354343 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61090300 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59534163 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58846284 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57022277 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56135057 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55944528 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53621802 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53472683 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53371311 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52623781 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52506706 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.50712462 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48336139 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47735571 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47661432 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47064626 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46742745 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.44421647 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.44168045 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43656223 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42751273 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39860093 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39755500 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39005790 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37180953 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34215465 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33799104 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.33773541 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32180613 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.31720122 |

